1 – 118 of 118
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Attenuated huntingtin gene CAG nucleotide repeat size in individuals with Lynch syndrome
(
- Contribution to journal › Article
- 2023
-
Mark
Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease : a study of linked Swedish National Registries (2002–2019)
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin expression in the hypothalamus promotes ventral striatal neuropathology
2023)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington's disease
(
- Contribution to journal › Article
- 2022
-
Mark
Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
2022)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
(
- Contribution to journal › Scientific review
-
Mark
Microarray profiling of hypothalamic gene expression changes in Huntington's disease mouse models
(
- Contribution to journal › Article
-
Mark
IKKβ signaling mediates metabolic changes in the hypothalamus of a Huntington disease mouse model
(
- Contribution to journal › Article
-
Mark
Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
(
- Contribution to journal › Article
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
(
- Contribution to journal › Article
- 2021
-
Mark
Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis
(
- Contribution to journal › Article
-
Mark
Early white matter pathology in the fornix of the limbic system in Huntington disease
(
- Contribution to journal › Article
-
Mark
Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood-onset craniopharyngioma
(
- Contribution to journal › Article
-
Mark
Effects of mutant huntingtin inactivation on Huntington disease-related behaviours in the BACHD mouse model
(
- Contribution to journal › Article
-
Mark
Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
(
- Contribution to journal › Article
- 2020
-
Mark
Huntingtons sjukdom – kliniska prövningar inger nu optimism - Vanligaste formen av ärftlig neurodegenerativ sjukdom i västvärlden ger svåra symtom och förtidig död
(
- Contribution to journal › Article
-
Mark
Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease
(
- Contribution to journal › Article
- 2019
-
Mark
SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease
(
- Contribution to journal › Article
-
Mark
Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity
(
- Contribution to journal › Article
-
Mark
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease
(
- Contribution to journal › Scientific review
-
Mark
The psychopharmacology of Huntington disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2018
-
Mark
Laminin α1 reduces muscular dystrophy in dy2Jmice
(
- Contribution to journal › Article
-
Mark
mHTT Seeding Activity : A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation
(
- Contribution to journal › Article
-
Mark
Thermoregulatory disorders in Huntington disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Thermoregulation in amyotrophic lateral sclerosis
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(37). p.8765-8774(
- Contribution to journal › Article
-
Mark
Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay
(
- Contribution to journal › Article
-
Mark
Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma
(
- Contribution to journal › Article
-
Mark
Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
-
Mark
Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis
(
- Contribution to journal › Article
-
Mark
Microstructure alterations in the hypothalamus in cranially radiated childhood leukaemia survivors but not in craniopharyngioma patients unaffected by hypothalamic damage
(
- Contribution to journal › Article
- 2016
-
Mark
Ethical aspects of a predictive test for Huntington's Disease: A long term perspective.
(
- Contribution to journal › Article
-
Mark
Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Subjective sleep problems in Huntington's disease : A pilot investigation of the relationship to brain structure, neurocognitive, and neuropsychiatric function
(
- Contribution to journal › Article
-
Mark
Associations between Metabolic Risk Factors and the Hypothalamic Volume in Childhood Leukemia Survivors Treated with Cranial Radiotherapy.
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease : increased NPY levels and differential degradation of the NPY1-30 fragment
(
- Contribution to journal › Article
-
Mark
Hypothalamic dysfunction revealed by magnetic resonance diffusion tensor imaging in childhood leukemia survivors treated with cranial radiotherapy but not in craniopharyngeoma survivors
2016) Endokrindagarna(
- Contribution to conference › Poster
- 2015
-
Mark
Volumetric analysis of the hypothalamus in Huntington Disease using 3T MRI: the IMAGE-HD Study.
(
- Contribution to journal › Article
-
Mark
Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue.
(
- Contribution to journal › Article
-
Mark
Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study.
(
- Contribution to journal › Letter
-
Mark
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.
(
- Contribution to journal › Article
-
Mark
Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.
(
- Contribution to journal › Article
- 2014
-
Mark
Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1α
(
- Contribution to journal › Article
-
Mark
Effects of Deletion of Mutant Huntingtin in Steroidogenic Factor 1 Neurons on the Psychiatric and Metabolic Phenotype in the BACHD Mouse Model of Huntington Disease.
(
- Contribution to journal › Article
-
Mark
Twisting mice move the dystonia field forward
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Maintenance of Basal Levels of Autophagy in Huntington's Disease Mouse Models Displaying Metabolic Dysfunction.
(
- Contribution to journal › Article
-
Mark
Ethical aspects of undergoing a predictive genetic testing for Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntingtons disease
(
- Contribution to journal › Article
-
Mark
Suicidal ideation in a European Huntington's disease population
(
- Contribution to journal › Article
- 2012
-
Mark
Progranulin Bridges Energy Homeostasis and Fronto-Temporal Dementia
(
- Contribution to journal › Letter
-
Mark
Characterization of a rat model of Huntington's disease based on targeted expression of mutant huntingtin in the forebrain using adeno-associated viral vectors.
(
- Contribution to journal › Article
-
Mark
For Better or for Worse: Lifeworld, System and Family Caregiving for a Chronic Genetic Disease.
(
- Contribution to journal › Article
-
Mark
Expression of Mutant Huntingtin in Leptin Receptor-Expressing Neurons Does Not Control the Metabolic and Psychiatric Phenotype of the BACHD Mouse.
(
- Contribution to journal › Article
- 2011
-
Mark
Eating and Hypothalamus Changes in Behavioral-Variant Frontotemporal Dementia
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits.
(
- Contribution to journal › Article
-
Mark
Increased numbers of orexin/hypocretin neurons in a genetic rat depression model.
(
- Contribution to journal › Article
-
Mark
Observing Huntington's disease : the European Huntington's Disease Network's REGISTRY
(
- Contribution to journal › Letter
- 2010
-
Mark
NEUROPEPTIDE AND HYPOTHALAMUS CHANGES IN FRONTOTEMPORAL DEMENTIA AND HUNTINGTON'S DISEASE
2010) 10th Biennial Meeting of the Asia-Pacific Society of Neurochemistry In Journal of Neurochemistry 115(Suppl. 1). p.1-1(
- Contribution to journal › Published meeting abstract
-
Mark
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons
(
- Contribution to journal › Article
-
Mark
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.
(
- Contribution to journal › Article
-
Mark
Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses.
(
- Contribution to journal › Article
-
Mark
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
(
- Contribution to journal › Article
-
Mark
Hypothalamic and Neuroendocrine Changes in Huntington's Disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article
-
Mark
Reduced CSF CART in dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.
(
- Contribution to journal › Article
-
Mark
Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model.
(
- Contribution to journal › Article
-
Mark
Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
(
- Contribution to journal › Article
-
Mark
Huntington's Disease - New Perspectives Based on Neuroendocrine Changes in Rodent Models.
(
- Contribution to journal › Article
-
Mark
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.
(
- Contribution to journal › Article
-
Mark
Malignt neuroleptikasyndrom--sällsynt diagnos med hög dödlighet.
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Cocaine and amphetamine regulated transcript (CART) in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Sex differences in a transgenic rat model of Huntington's disease: decreased 17 beta-estradiol levels correlate with reduced numbers of DARPP32(+) neurons in males
(
- Contribution to journal › Article
-
Mark
Role of neuroticism and neurochemical changes in suicidal behaviour
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.132-132(
- Contribution to journal › Published meeting abstract
-
Mark
Transthyretin in cerebrospinal fluid from suicide attempters.
(
- Contribution to journal › Article
-
Mark
Hippocampal cytogenesis is increased in FSL strain, a genetic rat model of depression. Escitalopram reduces increased cell number
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.124-125(
- Contribution to journal › Published meeting abstract
-
Mark
Increased metabolism in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Hippocampal cytogenesis is increased in a genetic rat model of depression. Escitalopram reduces increased cell number
2008) 21st Congress of the European-College-of-Neuropsychopharmacology In European Neuropsychopharmacology 18(S4). p.323-323(
- Contribution to journal › Published meeting abstract
-
Mark
Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus
(
- Contribution to journal › Article
-
Mark
Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model.
(
- Contribution to journal › Article
-
Mark
Islet beta-cell area and hormone expression are unaltered in Huntington's disease.
(
- Contribution to journal › Article
- 2007
-
Mark
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
(
- Contribution to journal › Article
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
-
Mark
Orexin and psychiatric symptoms in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
(
- Contribution to journal › Article
-
Mark
Testicular degeneration in Huntington disease
(
- Contribution to journal › Article
- 2006
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat
(
- Contribution to journal › Article
-
Mark
Hypothalamic-endocrine aspects in Huntington's disease.
(
- Contribution to journal › Scientific review
-
Mark
Laminin {alpha}1 chain improves laminin {alpha}2 chain deficient peripheral neuropathy.
(
- Contribution to journal › Article
- 2005
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
(
- Contribution to journal › Article
-
Mark
Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
-
Mark
Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient.
(
- Contribution to journal › Article
-
Mark
Proteolysis of NR2B by calpain in the hippocampus of epileptic rats.
(
- Contribution to journal › Article
-
Mark
Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.
(
- Contribution to journal › Article
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
(
- Contribution to journal › Article
- 2004
-
Mark
Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
(
- Contribution to journal › Article
- 2002
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
-
Mark
Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Huntington's disease: the mystery unfolds?
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
(
- Contribution to journal › Article
-
Mark
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine
(
- Contribution to journal › Article
-
Mark
Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death
(
- Contribution to journal › Article
-
Mark
Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors
(
- Contribution to journal › Article
-
Mark
Effects of dopamine and excitotoxicity in experimental models of Huntington's disease
2001)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Huntingtons sjukdom - ännu ett galet protein?
(
- Contribution to journal › Article
- 2000
-
Mark
Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor
(
- Contribution to journal › Article
-
Mark
Improving the survival of grafted dopaminergic neurons: a review over current approaches
(
- Contribution to journal › Article
-
Mark
Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons
(
- Contribution to journal › Article
-
Mark
Caspase inhibition increases embryonic striatal graft survival
(
- Contribution to journal › Article
- 1999
-
Mark
Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
(
- Contribution to journal › Article
-
Mark
Graft survival
(
- Contribution to journal › Letter